SCHEMBL24858710

SCHEMBL24858710

CC(C)(C)OC(=O)NCCOc1ccc(C(=O)O)cn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.54
▸ GABRA5 P31644 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ CA12 O43570 5/20 0.48
▸ CA1 P00915 5/20 0.48
▸ CA2 P00918 5/20 0.48
▸ CA9 Q16790 5/20 0.48
▸ IDO1 P14902 1/20 0.44
▸ SCN9A Q15858 1/20 0.44
▸ HCAR3 P49019 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ EPHX2 P34913 1/20 0.42
▸ CKS1B P61024 1/20 0.42
▸ SKP1 P63208 1/20 0.42
▸ SKP2 Q13309 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31286719 0.91 CA12 (0.51) MAPTGABRA5L3MBTL1CA12CA1
SCHEMBL24858709 0.89 CA12 (0.47) GABRA5L3MBTL1CA12CA1CA2
SCHEMBL30131245 0.84 CA12 (0.50) MAPTGABRA5L3MBTL1CA12CA1
SCHEMBL18530385 0.84 CA12 (0.50) GABRA5L3MBTL1CA12CA1CA2
SCHEMBL24858712 0.83 GABRA5 (0.46) GABRA5CA12CA1CA2CA9
SCHEMBL18530389 0.83 CA12 (0.49) GABRA5CA12CA1CA2CA9
SCHEMBL30564446 0.83 CA12 (0.49) GABRA5CA12CA1CA2CA9
SCHEMBL18289997 0.83 CA12 (0.49) GABRA5L3MBTL1CA12CA1CA2
SCHEMBL528927 0.83 CA12 (0.52) GABRA5CA12CA1CA2CA9
SCHEMBL29606964 0.82 CA12 (0.48) GABRA5L3MBTL1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023272410-A1 ERα RECEPTOR COVALENT BINDING ANTAGONIST 北京盛诺基医药科技股份有限公司 2023-01-05 — — WO disclosed
Send feedback